Bausch Health Companies | VRX - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Amgen USD 25.5B 547M 2026-06
ANI Pharmaceuticals USD 283.65M 44.14M 2026-06
Aurora Cannabis CAD 66.93M 79M 2026-03
Bausch Health Companies USD 4.54B 14M 2026-06
Biogen USD 3.92B 918.2M 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Canopy Growth CAD 158.44M 60.15M 2026-03
Corcept Therapeutics USD 153.8M 4.62M 2026-06
Danaher USD 8.1B 645M 2026-06
Drreddys Laboratories INR 167.57B 165.8B 2026-03
Eli Lilly USD 47.74B 11.11B 2026-06
Gilead Sciences USD 11.02B 1.54B 2026-06
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Novo Nordisk DKK 239.08B 13.92B 2026-06
Pacira USD 122.01M 13.22M 2026-06
Perrigo USD 1.05B 57.2M 2026-06
Phibro Animal Health USD 316.47M 34.6M 2026-06
Prestige Brands USD 153.81M 32.88M 2026-06
Supernus Pharmaceuticals USD 347.38M 26.55M 2026-06
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06
Zoetis USD 2.06B 8M 2026-06